Zacks: Brokerages Expect Acadia Healthcare Company Inc (ACHC) Will Post Quarterly Sales of $728.17 Million
Wall Street analysts expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to post sales of $728.17 million for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Acadia Healthcare’s earnings, with the lowest sales estimate coming in at $716.60 million and the highest estimate coming in at $738.60 million. Acadia Healthcare reported sales of $734.67 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 0.9%. The firm is scheduled to issue its next earnings report after the market closes on Tuesday, October 24th.
According to Zacks, analysts expect that Acadia Healthcare will report full-year sales of $728.17 million for the current year, with estimates ranging from $2.84 billion to $2.89 billion. For the next year, analysts forecast that the business will post sales of $3.09 billion per share, with estimates ranging from $3.03 billion to $3.12 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover Acadia Healthcare.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.63% and a net margin of 6.93%. The company had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. During the same quarter in the previous year, the firm earned $0.73 earnings per share. The business’s quarterly revenue was down 5.4% compared to the same quarter last year.
A number of equities analysts have recently commented on the stock. Mizuho increased their price objective on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. BMO Capital Markets started coverage on shares of Acadia Healthcare in a research note on Monday, October 16th. They issued an “outperform” rating and a $52.00 target price for the company. Craig Hallum reiterated a “buy” rating and issued a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 1st. Finally, Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $57.64.
In other Acadia Healthcare news, Director William Grieco sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $51.71, for a total transaction of $103,420.00. Following the completion of the sale, the director now directly owns 45,013 shares in the company, valued at $2,327,622.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Scott Schwieger sold 2,891 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $52.85, for a total transaction of $152,789.35. Following the sale, the insider now owns 8,841 shares of the company’s stock, valued at $467,246.85. The disclosure for this sale can be found here. Insiders have sold 3,085,693 shares of company stock valued at $157,729,099 over the last 90 days. Company insiders own 11.10% of the company’s stock.
A number of hedge funds have recently modified their holdings of ACHC. FMR LLC lifted its position in Acadia Healthcare by 173.2% during the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after acquiring an additional 1,391,552 shares during the last quarter. Teachers Advisors LLC lifted its position in Acadia Healthcare by 1.3% during the first quarter. Teachers Advisors LLC now owns 373,571 shares of the company’s stock worth $16,288,000 after acquiring an additional 4,886 shares during the last quarter. Legal & General Group Plc lifted its position in Acadia Healthcare by 226.4% during the first quarter. Legal & General Group Plc now owns 25,756 shares of the company’s stock worth $1,123,000 after acquiring an additional 17,865 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in Acadia Healthcare during the first quarter worth approximately $258,000. Finally, Vanguard Group Inc. lifted its position in Acadia Healthcare by 8.1% during the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after acquiring an additional 431,550 shares during the last quarter.
Shares of Acadia Healthcare (ACHC) opened at 44.45 on Monday. The firm has a 50 day moving average price of $45.65 and a 200-day moving average price of $46.30. The firm has a market cap of $3.91 billion, a PE ratio of 488.46 and a beta of 1.07. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.34.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Acadia Healthcare Company Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc and related stocks with our FREE daily email newsletter.